Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 6/20 | 0.68 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | ACACB | O00763 | 7/20 | 0.42 |
| ▸ | MMP12 | P39900 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | MMP14 | P50281 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | FPR2 | P25090 | 2/20 | 0.37 |
| ▸ | PROKR1 | Q8TCW9 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2363928 | 0.92 | KCNH2 (0.72) | KCNH2PTGS1SLC6A2SLC6A4ACACB | |
| SCHEMBL2363925 | 0.92 | KCNH2 (0.72) | KCNH2PTGS1SLC6A2SLC6A4ACACB | |
| SCHEMBL3664766 | 0.87 | KCNH2 (0.67) | KCNH2PTGS1SLC6A2SLC6A4ACACB | |
| SCHEMBL3664769 | 0.87 | KCNH2 (0.67) | KCNH2PTGS1SLC6A2SLC6A4ACACB | |
| SCHEMBL3028831 | 0.80 | KCNH2 (0.58) | KCNH2PTGS1SLC6A2SLC6A4ACACB | |
| SCHEMBL3028835 | 0.80 | KCNH2 (0.58) | KCNH2PTGS1SLC6A2SLC6A4ACACB | |
| SCHEMBL2056202 | 0.78 | KCNH2 (0.58) | KCNH2PTGS1SLC6A2SLC6A4ACACB | |
| SCHEMBL3038264 | 0.78 | KCNH2 (0.55) | KCNH2PTGS1SLC6A2SLC6A4CHRM4 | |
| SCHEMBL3038267 | 0.78 | KCNH2 (0.55) | KCNH2PTGS1SLC6A2SLC6A4CHRM4 | |
| SCHEMBL22527383 | 0.77 | KCNH2 (0.56) | KCNH2PTGS1SLC6A2SLC6A4ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250233206-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-07-17 | — | — | US | disclosed |
| US-20250171582-A1 | CURING AGENT COMPOSITION FOR THERMOSETTING RESIN, EPOXY RESIN COMPOSITION, AND FIBER-REINFORCED COMPOSITE MATERIAL | TEIJIN LIMITED (JP) | 2025-05-29 | — | — | US | disclosed |
| US-12315883-B2 | Non-aqueous electrolyte solution and non-aqueous electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-05-27 | — | — | US | disclosed |
| US-20250140732-A1 | UNDERFILL MATERIAL, SEMICONDUCTOR PACKAGE AND METHOD FOR PRODUCING SEMICONDUCTOR PACKAGE | RESONAC CORPORATION (JP) | 2025-05-01 | — | — | US | disclosed |
| EP-4524174-A1 | CURING AGENT AND USE THEREOF | Shikoku Chemicals Corporation (JP) | 2025-03-19 | — | — | EP | disclosed |
| US-12195636-B2 | Resin composition, cured product, sheet lamination material, resin sheet, printed wiring board, and semiconductor device, and method for producing printed wiring board | AJINOMOTO CO., INC. (JP) | 2025-01-14 | — | — | US | disclosed |
| WO-2024252940-A1 | COMPOUND AND COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2024-12-12 | — | — | WO | disclosed |
| EP-4471073-A1 | CURING AGENT COMPOSITION FOR THERMOSETTING RESIN, EPOXY RESIN COMPOSITION, AND FIBER-REINFORCED COMPOSITE MATERIAL | Teijin Limited (JP) | 2024-12-04 | — | — | EP | disclosed |
| WO-2024171777-A1 | COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION, CURED PRODUCT, DISPLAY DEVICE, AND SOLID-STATE IMAGE SENSOR | 住友化学株式会社 | 2024-08-22 | — | — | WO | disclosed |
| EP-4386032-A1 | FIBER-REINFORCED COMPOSITE MATERIAL AND PRODUCTION METHOD THEREFOR | Teijin Limited (JP) | 2024-06-19 | — | — | EP | disclosed |
| EP-2672561-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING SAME | Mitsubishi Chemical Corporation (JP) | 2013-12-11 | — | — | EP | disclosed |
| US-8598358-B2 | Synthetic intermediate of oxazole compound and method for producing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-12-03 | — | — | US | disclosed |
| US-20130316229-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-11-28 | — | — | US | disclosed |
| EP-2533254-A1 | REDUCING AGENT COMPOSITION FOR CONDUCTIVE METAL PASTE | Namics Corporation (JP) | 2012-12-12 | — | — | EP | disclosed |
| EP-2533344-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, ELECTROCHEMICAL ELEMENT USING SAME, AND ALKYNYL COMPOUND USED THEREFOR | Ube Industries, Ltd. (JP) | 2012-12-12 | — | — | EP | disclosed |
| EP-2528896-A1 | SYNTHETIC INTERMEDIATE OF OXAZOLE COMPOUND AND METHOD FOR PRODUCING THE SAME | Otsuka Pharmaceutical Co., Ltd. (JP) | 2012-12-05 | — | — | EP | disclosed |
| US-20120301797-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, ELECTROCHEMICAL ELEMENT USING SAME, AND ALKYNYL COMPOUND USED THEREFOR | UBE INDUSTRIES, LTD. (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120298929-A1 | REDUCING AGENT COMPOSITION FOR THE CONDUCTIVE METAL PASTE | NAMICS CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120302757-A1 | SYNTHETIC INTERMEDIATE OF OXAZOLE COMPOUND AND METHOD FOR PRODUCING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-11-29 | — | — | US | disclosed |
| WO-2011093529-A1 | SYNTHETIC INTERMEDIATE OF OXAZOLE COMPOUND AND METHOD FOR PRODUCING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302757-A1 | SYNTHETIC INTERMEDIATE OF OXAZOLE COMPOUND AND METHOD FOR PRODUCING THE SAME | GLP1R, HBB, OXA1L | KCNH2 2417/4885PTGS1 3299/4885SLC6A2 4032/4885 |
| US-20120301797-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, ELECTROCHEMICAL ELEMENT USING SAME, AND ALKYNYL COMPOUND USED THEREFOR | WEE2, WEE1, NOTUM | KCNH2 200/4885PTGS1 3042/4885SLC6A2 3024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.